European Commission opens consultations on the revision of the EU legislation on blood, tissue and cells

The Commission launched a public consultation and a targeted consultation on the revision of the EU Blood, Tissue and Cells directive. The aim of these is to collect views and opinions on the proposed policy options. The public consultation is open to any individual or organisation that would like to provide input on the revision. The targeted consultation is addressed to organisations directly involved in or affected by the directive, thus knowledgeable about the legal framework. The two consultations will close on the 15th April 2021. Further, the Commission will organise meetings with stakeholder organisations to gather additional evidence. More information can be found here.

Stay up to date

    © CSL 2026

    Blood & Beyond is a multi-stakeholder initiative funded by CSL, involving experts from the fields of haematology, transfusion medicine, anaesthesiology, patient blood management, nursing, patient advocacy, health economics, and hospital management, with support from policymakers committed to driving improvements in this area. The aim of the initiative is to raise awareness of the importance of good blood health and of the impact of anaemia on patients, healthcare systems and society at large, with the overarching goal to help advance policies and practices that improve patient outcomes by supporting patient-centricity in anaemia prevention, diagnosis, and management through patient blood management (PBM) and innovation.

    Contact

    For further information and queries, please contact the Blood and Beyond Secretariat: javier.lopezpanos@dgagroup.com

    Privacy Preference Center